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Summary: Four different, well known colour reagents for iron determination were tested in a citrate buffer
at pH 2.0 under the same automated standard conditions and compared with a manual reference method on
human serum and plasma samples. Specific results were obtained only with the chromogen tripyridyl-s-
triazine. A micromethod was developed, which is generally well suited for automated, direct serum iron
determinations, with respect to good flow properties, simple reagent composition, high reagent stability, rapid
colour development, stable colour complex and high specificity. This method was run on either a Gilford
System 203 S, Gilford Impact 400 or a Greiner G-400 analyser and adapted to the Technicon SMAC II,
Technicon RA 1000, Eppendorf Epos and Abbott Spectrum automated systems. The tripyridyl-s-triazine
method permits the determination of ferrioxainine iron in urine after a simple sample pretreatment.
introduction , , * * j j r -
several other automated methods for serum iron de-
The first automated method for serum iron measure- termination have been introduced in the routine lab-
rnent was developed on a continuous flow system with oratory (2—9). These methods were mainly based on
the chromogen tripyridyl-s-triazine (1). Subsequently, the colour reagents bathophenanthroline sulphonate
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and ferrozine. The latter chromogen has a somewhat
higher molar absorptivity than tripyridyl-s-triazine
and bathophenanthroline sulphonate. Later, ferene-
S, a chromogen with improved molar absorptivity
and the same features as ferrozine, with respect to
slow colour development and interference by copper
(10), was introduced for serum iron determination
(11). The relatively slow colour development in the
ferrozine reaction was found to be a limiting factor
in some analysers (6). Interference by copper can be
eliminated with thiosemicarbazide, which forms an
uncoloured complex with copper (10). Reaction of
thiosemicarbazide with ascorbic acid impairs reagent
stability. If the test is not performed at sufficiently
acidic pH, interference by released haemoglobin iron
may arise (10). Such difficulties may easily impair the
specificity of the measurement, in particular in the
clinically important, abnormally low range. We
searched for an improved, automated method for
serum iron determination, which overcomes these
problems.
Materials and Methods
Chemicals
Bathophenanthroline suJphonate (4,7-diphenyl-l. 10-phenan-
throline disulphonic acid sodium salt), TPTZ (2,4,6-tripyridyl-
s-triazine), ferrozine (3-(2-pyridyl)-5,6-bis(4-phenylsulphonic
acid)-l,2,4-triazine sodium salt) and ferene-S (3-(2-pyridyl)-5,6-
bis(2-(5-furyl-sulphonic acid))-l ,3,4-triazine disodium salt) were
from Sigma Chem. Corp., Duishofen, FRG. Other analytical
grade reagents were obtained from E. Merck Darmstadt, FRG.
The iron standard was either from Boehringer Mannheim, FRG
(17.9 μιηοΐ/ΐ) or prepared from a stock solution, containing
895.5 μηιοΙ/1 iron. The stock solution was made by dissolving
reduced iron in approx 6 mol/1 HC1, followed by dilution to 1 1
with distilled water.
Serum and plasma samples
Control sera were obtained from E. Merck, Darmstadt, FRG
(Seronorm), from Beckman, Munich, FRG (Decision Level
1 —3) and from Behringwerke, Marburg, FRG (Kontrollogen-
LP).
Serum or plasma samples from patients with normal and path-
ological iron values were used. Sampling was performed be-
tween 8 and 9 a. m. under fasting conditions. Tubes containing
ammonium heparinate were used for obtaining plasma.
Instrumentat ion
In the present investigation, serum (plasma) iron and urine
desferal iron determinations were performed either on a Gilford
System 203 S, a Gilford Impact 400 Analyser (Gilford Instru-
ments, Oberlin, OH, USA) or a Greiner G-400 analyser (Greiner
Instruments GmbH, Birkenfeld, FRG). Only the tripyridyl-s-
triazine method was adaptable to the Greiner G-400 (at 37 °C).
Atomic absorption spectrophotometric determinations of iron
in urine were performed on a Perkin-Elmer 2380 system (Perkin-
Elmer Corp., Norwalk, Ct., USA).
Reagents
The reagent for sample blanks (reagent 1) consisted of 0.24
mol/1 aqueous citric acid monohydrate (50 g/1 + 1 drop of
chloroform) and 5.6 mmol/1 ascorbic acid. The colour reagent
(reagent 2) consisted of 1.6 mmol/l of one of the reagents,
tripyridyl-s-triazme, bathophenanthroline sulphonate, ferrozine
or ferene-S dissolved in reagent 1. Total-'bilirubin was measured
on a Greiner G-40 with the dichloroaniline method (kit from
Greiner No. 4057).
Method for serum (plasma) examinations
The methods were run with sample and reagent blanks at 25 °C
on the Gilford Systems with four different standards (2.2, 4.5,
9.0 and 17.9 μτηοΐ/ΐ) and at 37 °C on the Greiner G-400 with
or without standards. Details for the programming of these
systems are listed in table 1. The measurements were performed
at a wavelength of 593, 533, 562 and 593 nm with tripyridyl-s-
triazine, bathophenanthroline sulphpnatej ferrozine and ferene-
S, respectively. The tripyridyks-triazine/citrate method was
found to be linear up to at least 260 μιηοΐ/l. For the examination
of urine samples, higher standards were used (see below). The
systems were accepted for use when they showed linearity for
the different standards (automatically checked) and/or a within-
run precision of 2% or less in a control serum (Decision Level
2). Otherwise, a cleaning of the system with 0.1 rnol/I HC1 and/
or a photometer check (lamp drift) was performed, After an
initial cleaning with HC1, problems of contamination normally
do not occur in selective analysers such as the Greiner G-400
and comparable systems.
Tab. 1. Data on the programming of the Gilford systems and
the Greiner G-400.
Gilford
WAWELENGTH
TRANSPORT TEMP.
CUVETTE TEMP.
SAMPLE VOLUME
VOLUME DISP. A
VOLUME DISP. B
VOLUME DISP. C
READ TIME
EQUIL. TIME
TIME A TO B
TIME A TO C
LAG TIME
593
25
25
40
100
300
300
3
5
2
2
300
Greiner G-400
MODE
N/U
PT1
PT2
FILTER
Rl
R2
A
B
VOLUME Rl
VOLUME R2
SAMPLE VOLUME
50
39
030
030
7 0 0 0
01
10
5494
-13
400
400
30
0
030
030
0
39
38
• i
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Reference method
A manual reference method with the chromogen bathophen-
anthroline sulphonate with deproteinisation (kit from Boehrin-
ger Mannheim, FRG No. 124214), which is comparable with
the recommended method of The International Committee for
Standardization in Hematology (12) was used.
Methods for urine examination
Standards of 17.9, 90.0, 179.1, and 358.2 μιηοΐ/ΐ and the same
reagents and programming as for serum and plasma determi-
nations (s. above) were used.
Pretreatment of urine samples
The urine samples were diluted 1:3.5 with a solution containing
citric acid (0.57 mol/1) and ascorbic acid (0.48 mol/1); 0.5 ml of
this diluted solution was placed in a capped micro reaction
vessel and kept in a heat block (Eppendorf 3401, Eppendorf
Ger tebau, Hamburg, FRG) at 56 °C for 15 min. After this
pretreatment, the urine sample was assayed automatically as
described above. If the total amount of ferrioxamine iron and
transferrin iron in serum is to be determined, serum can be
pretreated in the same manner.
0.8η /^OOOOOO
0.2
Fig. L Colour development and intensity of the four tested
chromogens at different pHs by the use of citrate/HCl/
NaOH buffer.
Ο = Ferene-S
D = Ferrozine
Δ = 2,4,6-Tripyridyl-s-triazine
ο = Bathophenanthroh'ne sulphonate
Results
Investigation of different chromogens
The reaction time for total colour development was
found to be 30 s for tripyridyl-s-triazine, 2 min for
bathophenanthroline sulphonate and ferrozine and
l h for ferene-S, examined at 25 °C and at a pH of
1.85 (see tab. 2). The four different chromogens were
tested under the same standard conditions, using 0.24
mol/1 citric acid/-HCl-NaOH buffer. Figure 1 indi-
cates that tripyridyl-s-triazine has a constant colour
intensity in the pH range between 1.6 and 4.0 and
bathophenanthroline sulphonate in the pH range 1.3
to at least 6.0. The chromogens ferrozine and ferene-
S were found to have a somewhat less constant colour
intensity between pH 1.6 and 4.6 and between pH 1.7
and 4.6, respectively. All reagents were found to be
Tab. 2. Some features of the four different chromogens under
the same standard conditions (citrate buffer, pH 2.0).
Colour
reagent
Tripyridyl-
s-triazine
Bathophen-
anthroline
sulphonate
Ferrozine
Ferene-S
Reaction Solu- .
time bility
(min)
0.5 +
2.0 +
2.0 +
60.0 +
Molar
absorptivity
under test
conditions
(m2/mol)
220660
219210
282360
360020
stable for at least 2 months at 4 —8 °C and 1 week at
room temperature. The colour complexes of tripyri-
dyl-s-triazine and ference-S were found to be stable
for at least 72 h, and for bathophenanthroline sul-
phonate and ferrozine for at least 36 and 24 h, re-
spectively. The interference of copper in the tripyridyl-
s-triazine/citrate method was found to be less than
2.0% in a plasma with various concentrations of
added copper chloride, as described in detail elsewhere
(13).
Correlations with the reference method
Sixty different plasma samples from patients were
tested with tripyridyl-s-triazine, bathophenanthroline
sulphonate, ferrozine and ferene-S and the results
compared with those from the reference method. In
figure 2 a, it is shown that a good correlation was
obtained with the tripyridyl-s-triazine method. No
interference was observed in this method in icteric,
lipaemic or haemolytic plasmas. These findings show
clearly that the tripyridyl-s-triazine/citrate method is
specific and sensitive for iron determination in human
blood. This method detects iron concentrations of less
than 0.2 μπιοΐ/ΐ. Distinctly turbid, lipaemic sera may
impair precision and should be pretreated with a
commonly available cleaning agent. Interference with
the determination of haemoglobin iron arise at 37 °C
on the Greiner system in plasmas with a haemoglobin
content of 0.8 g/1 or more. In the other systems,
haemoglobin contents up to 5.0 g/1 did not interfere,
as demonstrated in table 3. In figure 2 it is shown
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Fig. 2. Correlation data of the four different chromogens with the manual reference method in plasma samples from patients.
The chromogens were tested under the same standard conditions (citrate buffer pH 2.0).
a) 2,4,6-Tripyridyl-s-triazine (TPTZ)
Total range: n = 60; r = 0.996; y = 0.1035 χ - 0.508
Range 0.7-10.2 μιηοΐ/l: η = 25; r = 0.916; y = 0.948 χ + 0.068
Range 10.3-63.4 μτηοΐ/l: n = 35; r = 0.995; y = 1.045 χ - 0.854
b) Bathophenanthroline
Total r nge: n = 60; r = 0.983; y = 1.002 χ
Range 0.7-10.2 μιηοΐ/ΐ: n = 25; r = 0.874; y = 1.154 χ +
Range 10.3-13.4 μηιοΐ/ΐ: n = 35; r = 0.974; y = 1.03 χ +
*) plasma sample with a bilirubin content of 73.5 μτηοΙ/1.
**) plasma sample with a bilirubin content of 287.3 μιηοΐ/ΐ.
c) Ferrocine
Total range: η = 60; r = 0.992; y = 0.977 χ -ί
Range 0.7-10.2 μπιοΐ/l: η = 25; r = 0.898; y
Range 10.3-63.4 μιηοΐ/l: n = 35; r = 0.990; y
d) Ferene-S
Total r nge: n = 59; r
1.066 χ
1.005x
1.187
0.776
0.093
2.247
2.078
1.285
Range 0.7-10.2 μιηοΐ/ί: η = 24; r = 0.879; y = Ϊ!θ16°χ
Range 10.3-63.4 μιηοΐ/l: n = 35; r = 0.989; y = 1.023 χ
0.992; y = 0.997„x + 2.835
3.030
1.933
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Tab. 3. Determination of iron in haemolytic plasma samples.
From a blood sample, erythrocytes were haemolysed in
distilled water and diluted to different concentrations.
Separate fractions of the plasma sample were mixed
with the same volume of one of the haemolysate dilu-
tions. The expected value was determined after addition
of the same volume of distilled water to a plasma
fraction. Haemoglobin was determined with the cyan-
methaemoglobin method on a Gilford Stasar III spec-
tral photometer (Gilford Instruments, Oberlin, OH,
USA).
Tab. 4. List of results (μηιοΐ/ΐ) of the four tested methods under
the same standard conditions in plasma samples in the
pathologically decreased range.
Hb concentration
(g/D
0.62
1.25
2.50
5.05
Expected value
(μπιοΐ/ΐ)
12.2
12.2
12.2
12.2
Found value
(μηιοΐ/ΐ)
12.5
12.2
12.0
12.3
that the other chromogens have a considerably posi-
tive error, particularly in the pathologically decreased
range, as also demonstrated in table 4. In plasmas
with iron concentrations above 10.2 μιηοΐ/ΐ the cor-
relation with the reference method was found to be
improved, and the difference between the 4 different
chromogens was found to be almost balanced. Two
plasma samples with elevated total bilirubin concen-
tration were found to have a falsely positive error in
the bathophenanthroline sulphonate/citrate method
at pH 2.0. These plasma samples (fig. 2b * and **)
had bilirubin concentrations of 73.5 and 278.3 μήΐοΐ/ΐ,
respectively, indicating that bilirubin interferes with
this method. The latter finding was confirmed in a
pooled plasma from 12 different icteric patients. In
this pooled plasma, the following data were obtained:
total bilirubin = 155.6 μιηοΐ/ΐ, iron concentration in
the tripyridyl-s-triazine method = 17.6 μιηοΐ/ΐ, iron
concentration in the bathophenanthroline sulphonate
method == 24.7 μιηοΐ/l, positive error in the batho-
1
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0.40
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2.00
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2.50
6.40
4.50
2.50
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3.40
5.70
5.00
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3.90
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8.10
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6.60
7.90
9.00
8.60
9.30
9.90
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2.00
0.50
3.90
3.20
4.10
5.00
9.10
4.80
3.90
4.50
6.10
9.70
7.20
6.80
7.50
7.90
7.90
8.20
9.70
12.70
11.30
10.60
14.50
9.30
11.10
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5.00
3.90
5.60
—
7.00
6.40
7.50
6.80
6.40
7.20
4.30
10.90
10.60
8.60
8.60
9.30
9.30
9.30
12.50
13.30
9.50
10.40
13.30
13.60
13.80
phenanthroline sulphonate method = 40.3%. By in-
creasing (decreased plasma/reagent ratio) the pH in
the direct bathophenanthroline sulphonate method
from pH 2.0 to pH 4.0, the interference by bilirubin
was abolished. Thus, the bathophenanthroline sul-
phonate/citrate method seems to be specific for iron
measurement at the latter pH. No significant differ-
ence in the iron concentration could be detected be-
tween human serum and plasma.
Tab. 5. Data on the intra-assay precision of the tripyridyl-s-triazine method in different control sera.
Control
serum
Decision L 1
(Beckman)
Decision L 2
(Beckman)
Decision L 3
(Beckman)
Kontrollogen-LP
(Behringwerke)
Serononn
(E. Merck)
Charge
No.
C 401202
C 401203
C 401 204
623208
162
Assigned
value1
(μιηοΐ/ΐ)
21.1
28.8
41.5
35.52
26.3
η
30
30
30
30
30
Found
mean value
(μιηοΐ/ΐ)
22.5
32.2
47.0
41.2
26.4
SD
0.25
0.30
0.34
0.89
0.48
CV
(%)
1.11
0.93
0.72
2.17
1.82
1
 bathophenanthroline sulphonate without deproteinization.
2
 ferrozine without deproteinization.
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Accuracy and precision in control sera
The best precision in the tripyridyl-s-triazine method
was obtained in non-lyophilized sera with a CV rang-
ing from 0.72 to 1.11% (within one run), as shown
in table 5. The day-to-day variation and mean accu-
racy for Seronorm were 2.4% and + 0.5%, respec-
tively.
Adaptation to other automated systems
The tripyridyl-s-triazine/citrate method was adapted
to a Technicon SMAC II and Technicon RA 1000
(13), Eppendorf Epos and Abbot Spectrum auto-
mated analysers. The method can be run at any com-
monly used temperature. In the latter two systems,
some modifications are necessary1).
500
'
Μ
t 200
•J 100
100 200 300 400
Urine iron (atomic absorption) L<umol / lD
500
Fig. 3. Correlation data of the 2,4,6-tripyridyl-s-triazine
(TPTZ) method with the atomic absorption spectro-
photometric method in urine samples,
n = 26; r = 0.992; y = 0.950 χ + 5.834
Ferrioxamine iron in urine
In order to release all desferal-bound iron during
sample pretreatment at 56 °C, different molarities of
citric acid and ascorbic acid were investigated. At 0.57
mol/1 citric acid and 0.48 mol/1 ascorbic acid, all
ferrioxamine-bound iron was released for the tripyr-
idyl-s-triazine reaction, as determined in urines with
known ferrioxamine iron content. This pretreatment
can also be used for serum samples, if both ferriox-
amine iron and transferrin iron are to be determined.
') Data on the programming of the Eppendorf Epos and Ab-
bott Spectrum systems are available from the author.
The correlation data between the tripyridyl-s-triazine
method and the atomic absorption method in urine
samples is demonstrated in figure 3. These findings
are in accordance to the data obtained in iron-free
urine samples after addition of desferal and iron (II)
chloride at various concentrationsr(not shown).
Discussion
The present investigation clearly shows that our tri-
pyridyl-s-triazine/citrate method is specific and sen-
sitive for direct iron measurements in human blood,
and even in plasmas with iron values of 0.2 μιηοΐ/ΐ or
less. The high specificity of tripyridyl-Sr-triazine is con-
sistent with an earlier report (14). Moreover, the sim-
ple reagent composition, high reagent stability and
the instant colour development in the tripyridyl-s-
triazine method are features of great practical impor-
tance, which facilitate an adaptation to other auto-
mated systems. It has previously been pointed out
that tripyridyl-s-triazine, in contrast to ferrozine, is
quite insoluble in water (14--15). This seems to be
the main reason why tripyridyl-s-triazine has found
only limited use. Under our standard conditions, at
an acidic pH, tripyridyl-s-triazine was totally soluble
within few minutes.
The reaction time of l h found with ferene-S is some-
what longer than reported by Eskelinen (11). Colour
development within approx. 2 min in the bathophen:
anthroline sulphonate- and ferrozine methods and
within approx. 30 s for tripyridyl-s-triazine is there-
fore an obvious advantage. In our automated systems,
a relatively good precision was obtained with ferene-
S, even after an incubation time of only 5 min. The
high sensitivity of ferene-S is only of limited value
under these conditions. On the other hand, a reaction
time of more than 5 to 10 min limits the usef llness
of a method in an automated system. The positive
error in the ferrozine and ferene-S method indicates
interference by copper, in accordance with an earlier
report (11). We have no explanation at present for
the interference of bilirubin at pH 2.0 in the direct
bathophenanthroline sulphonate/citrate method. In
view of this interference, the bathophenanthroline sul-
phonate method is not suitable as a micromethod
under our standard conditions. In contrast to batho-
phenanthroline sulphonate, tripyridyl-s-triazine is
available at low cost.
Both the reducing and chelating effect of citric acid
and the rapid release of iron from transferrin at the
low pH are advantageous. The coloured ferroin com-
plexes also seem to be stabilized in our method, giving
a constant colour development hva relatively wide
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pH-range, in contrast to HCl-glycine-Tween buffer at
the same pH (16). By the use of less sensitive photo-
metric equipment, the latter finding enables a decrease
in the ratio, sample/reagent volume, and hence an
increase in pH.
The wide linear range of the ferrioxamine iron deter-
mination in urine samples with a high iron content is
advantageous. During desferal treatment, an increase
in the serum iron concentration occurs (17). Without
pretreatment of the serum samples, our method will
release some ferrioxamine iron. Since desferal partly
binds transferrin iron (18), a decrease in the serum
transferrin iron during desferal treatment can be ex-
pected. The quantity of released ferrioxamine iron
may vary widely under different standard conditions.
Direct serum iron determinations during desferal ther-
apy might thus be rather uncertain. In contrast to an
earlier report (19), we found no evidence for the
sensitivity of tripyridyl-s-triazine to desferal under our
standard conditions. Pretreatment of samples permits
the determination of the total ferrioxamine iron and
transferrin iron in serum.
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